Ulrike Mende

Title: Ulrike Mende: Innovator in Cardiotoxicity Evaluation

Introduction

Ulrike Mende is a notable inventor based in Norfolk, MA (US), recognized for her contributions to the field of cardiotoxicity evaluation. She holds a patent for a groundbreaking invention that enhances the assessment of cardiotoxicity using advanced human tissue models. Her work is pivotal in ensuring the safety of pharmaceutical and environmental compounds.

Latest Patents

Ulrike Mende's patent, titled "Human in vitro cardiotoxicity model - The Cardio-Tox Tissue Engineered Model (TEEM)," provides a robust in vitro model for cardiotoxicity evaluation. This invention utilizes three-dimensional (3D) human heart microtissues to quantify dose-dependent changes in electromechanical activity. It results in a comprehensive cardiotoxicity and arrhythmia risk assessment of test compounds. Additionally, the invention offers a predictive in vitro screening platform for pro-arrhythmic toxicity testing, enabling the screening of various compounds to establish safe human exposure levels.

Career Highlights

Throughout her career, Ulrike has worked with esteemed institutions such as Rhode Island Hospital and Brown University. Her innovative approach to cardiotoxicity evaluation has positioned her as a leader in her field. She has made significant strides in developing models that improve the safety assessment of new drugs and chemicals.

Collaborations

Ulrike Mende has collaborated with notable colleagues, including Bum-Rak Choi and Kareen L K Coulombe. These partnerships have furthered her research and contributed to advancements in cardiotoxicity evaluation.

Conclusion

Ulrike Mende's work in developing the Cardio-Tox Tissue Engineered Model represents a significant advancement in the field of cardiotoxicity evaluation. Her innovative contributions are essential for ensuring the safety of new compounds and protecting human health.